PhaseBio Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
PhaseBio Pharmaceuticals Inc
CIK #0001169245
EDGAR Form CIK 2011 - 2024
10-K [0001169245]
10-Q [0001169245]
3 [0001169245]
4 [0001169245]
8-K [0001169245]
D [0001169245]
SC 13D [0001169245]
SC 13G [0001169245]
Form 13D/13G Filer Form 13D/13G Subject Filed
Wellington Management Group LLP PhaseBio Pharmaceuticals Inc [2022-02-04]
Rosalind Advisors Inc PhaseBio Pharmaceuticals Inc [2021-05-19]
RA Capital Management LP PhaseBio Pharmaceuticals Inc [2021-03-24]
Avidity Partners Management LP PhaseBio Pharmaceuticals Inc [2021-03-22]
Rock Springs Capital Management LP PhaseBio Pharmaceuticals Inc [2020-11-16]
Rock Springs Capital Management LP PhaseBio Pharmaceuticals Inc [2019-04-22]
Johnson & Johnson PhaseBio Pharmaceuticals Inc [2019-01-22]
Wellington Management Group LLP PhaseBio Pharmaceuticals Inc [2018-11-13]
Hatteras Venture Advisors III LLC PhaseBio Pharmaceuticals Inc [2018-11-01]
New Enterprise Associates 13 LP PhaseBio Pharmaceuticals Inc [2018-10-31]
View All
Form 3/4/5 Subject 2011 - 2024
PhaseBio Pharmaceuticals Inc
Sapir Alex
Hutson Nancy J
Loewy Caroline M
van den Broek Richard
Thorp Clay
Humphries William D.
Harrigan Edmund
Sandell Scott D
NEA Partners 13, Limited Partnership
View All
Terms | Privacy | Guide
tony@aum13f.com